IIVS | 2017 July
0
archive,date,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-4.11.2.1,vc_responsive

July 2017

IIVS e-News – August 2017

July 27, 2017
...

IIVS Presented with Commendation from State and Local Officials

July 24, 2017
Maryland State Senator Cheryl Kagan and City of Gaithersburg Councilwoman Yvette Monroe visited our new respiratory exposure laboratory earlier this month.  IIVS CEO, Rodger Curren, and COO, Hans Raabe, walked through the capabilities of the new lab with Sen. Kagan and Councilwoman Monroe, and provided information about non-animal testing. IIVS was presented with a commendation in recognition of the opening of the new laboratory. ...

IIVS at the World Congress Alternatives and Animal Use in the Life Sciences

July 19, 2017
We are looking forward to attending the upcoming Tenth World Congress: Alternatives and Animal Use in the Life Sciences, August 20-24, 2017 in Seattle, WA.  We have several presentations and posters at the meeting, listed below.  If you will be attending, please stop by our booth - #202 - and talk with our officers and staff.  We look forward to seeing you! Presentations Tuesday, August 22, 2017 10:00 am - Noon Session IX-4: Global Regulatory Updates Collaborative industry and regulatory efforts to implement alternative methods...

Advances in Science: Next Generation of Lab Tools, Models and Testing Platforms Used in Predictive Toxicology

July 19, 2017
By Dr. Gertrude-Emilia Costin Toxicology testing platforms represent the basis of the human health risk assessment process that determines whether a material or product may induce harm to humans upon exposure. Historically, safety assessment of raw ingredients or finished formulations has been performed using animal-based test methods (in vivo) that provide whole organism responses to toxicants. Due to the large number of products launched by industry continuously, modern toxicology shifted in recent years towards the use of novel, fast and reliable alternative methods, ranging from in...

Webinar: Skin Tone Modulation: In Vitro Pre-clinical and Clinical Efficacy Testing Strategies and Innovative Solutions in Cosmetics

July 13, 2017
Addressing uneven skin tone often associated with photo-aging is a key area of interest in the cosmetic industry. The design of novel, safe, and efficacious actives and ingredients capable of inducing subtle changes in skin tone can be accomplished using modern, relevant and reliable pre-clinical testing strategies prior to clinical assessment. During this one-hour webinar, IIVS Study Director, Dr. Gertrude-Emilia Costin and Dr. Manpreet Randhawa, Principal Scientist at Johnson & Johnson, discuss optimized in vitro testing platforms using pigmented tissue models...

IIVS Recipient of Device that Mimics Human Exposure to Aerosols

July 10, 2017
PETA International Science Consortium Donates VITROCELL® In Vitro Inhalation Exposure System GAITHERSBURG, MD – July 10, 2017 – The Institute for In Vitro Sciences (IIVS), a leader in non-animal test methods, is the recipient of a VITROCELL® inhalation exposure system thanks to a generous donation by the PETA International Science Consortium. The device, which is designed to replace animals in inhalation testing, can be used to expose human lung cells to airborne test materials in an environment that mimics the human lung. IIVS will use...

IIVS Works with MAC Cosmetics and Others to Reduce and Eliminate Animal Testing

July 10, 2017
Eliminating animal testing is core to our mission. With the support of contributors like MAC Cosmetics,  we are making real progress.  Read this article in Teen Vogue that talks about our work and how companies like MAC Cosmetics are making a difference.  Read article....